Co-Authors
This is a "connection" page, showing publications co-authored by JAMES C YAO and CATHY ENG.
Connection Strength
0.263
-
FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer. Future Oncol. 2021 Aug; 17(24):3151-3162.
Score: 0.204
-
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. Lancet. 2023 07 01; 402(10395):41-53.
Score: 0.059